RxDoctor Payments Data

Kayla Bond, APRN

Nurse Practitioner · Searcy, ARNPI 1255912705

Payments from drug & device makers

$2,297in general payments, 2019–2025

Across 135 payments — averaging $17.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$569
  • Merck$362
  • Pfizer$162
  • AstraZeneca$157
  • Johnson & Johnson$129
  • Boehringer Ingelheim$99
  • plus $819 from 16 others

What the payments were for

  • Food & beverage$2,14393%
  • Education$1547%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,297 in reported general payments places this provider in the 80th percentile of 697 nurse practitioner providers in Arkansas.

See all nurse practitioner providers in Arkansas

Medicare billing

Part B allowed, 2024
$22,297
Medicare patients
192
Services billed
497

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EntrestoSacubitril/Valsartan206$134,200
EliquisApixaban91$58,452
FarxigaDapagliflozin Propanediol97$57,837
JardianceEmpagliflozin45$30,454
Ranolazine ErRanolazine46$3,433
Clonidine24$1,940
Valsartan123$1,911
Metoprolol Succinate174$1,537
Atorvastatin Calcium192$1,400
Nifedipine ErNifedipine25$988
Propafenone Hcl24$970
Spironolactone206$922
Rosuvastatin Calcium101$775
Carvedilol142$656
Amiodarone Hcl14$655

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
NovartisEntresto$569$134,200206 claims
PfizerEliquis$162$58,45291 claims
AstraZenecaFarxiga$157$57,83797 claims
Boehringer IngelheimJardiance$99$30,45445 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 697 nurse practitioner providers in Arkansas.

Other nurse practitioner in Searcy

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →